Are you physically less likely to become infected with COVID-19?

Embargoed until: Publicly released: 2022-04-12 01:00

International

Photo by Sangharsh Lohakare on Unsplash

At least seven different physical properties or characteristics of the body - which are known as phenotypes and are partly the result of genes and partly the result of your environment - can help people avoid catching or suffering severe disease from COVID-19, according to a study by genealogy company AncestryDNA. These newly-identified phenotypes are associated with regions of the genetic code that reduce the risk of COVID-19, the researchers say. The team surveyed 700,000 AncestryDNA customers about their COVID-19 outcomes to look for patterns in genetics and phenotypes among those who had come through the pandemic relatively unscathed. The researchers say the results confirmed four previously identified phenotypes associated with lower risks of severe COVID-19, as well as three new phenotypes associated with avoiding COVID-19 infection after a household exposure, and experiencing fewer symptoms.

Media release

From: Springer Nature

COVID-19: Identifying genetic susceptibility to COVID-19 based on self-reported outcomes

Three newly-defined phenotypes (observable characteristics or traits for an individual) that capture genetic associations which may provide protection against SARS-CoV-2, are presented in a study published in Nature Genetics. The findings — revealed through the analysis of self-reported outcomes of COVID-19 from over 700,000 customers in the United States of a DNA testing company — suggest that this method of data collection can complement clinical studies of COVID-19, notably for milder cases of the disease.

Genetic association studies can help to identify the genes and biological pathways underlying a given physical outcome or trait. Large-scale genetic studies of susceptibility to COVID-19 have focused on severe disease that is associated with hospitalisation. However, most infections with SARS-CoV-2 do not lead to severe disease, and although many clinical risk factors — such as age, body-mass index or sex — are known, these do not fully explain the variation in outcomes.

Kristin Rand and colleagues analysed self-reported outcomes of COVID-19 in questionnaires collected from 736,723 customers in the United States of a DNA testing company (median age of 57 years; 67% female). Using these genetic and survey data, the authors analysed four previously studied phenotypes related to the risk of developing severe disease. The team also defined three new, protective phenotypes related to the risk of infection following household exposure to SARS-CoV-2 and to symptom severity. These newly-identified phenotypes are associated with regions of the genetic code that reduce the risk of COVID-19 and therefore may be useful targets for therapeutic intervention.

This research demonstrates that large-scale, survey-based analysis of direct-to-consumer testing can complement traditional studies in hospitalised populations — an approach that the authors suggest could be applied to other diseases going forward.

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research Springer Nature, Web page The URL will go live after the embargo ends

Journal/
conference: Nature Genetics

Research:Paper

Organisation/s: AncestryDNA, USA

Funder: AncestryDNA. All authors are employed by Ancestry and may have equity in Ancestry.

Media Contact/s

Contact details are only visible to registered journalists.